Qianhong Pharmaceutical (002550.SZ) applied to issue convertible bonds to unspecified objects and obtained the approval of registration from the China Securities Regulatory Commission.

-Infomation from the Zhixin Finance and Economics APP: Biostar Pharmaceuticals (002550.SZ) has announced that the company recently received approval from the China Securities Regulatory Commission for the registration of convertible corporate bonds issued by Qianhong Biochemical Pharmaceutical Co., Ltd., allowing the company to proceed with the issuance of convertible corporate bonds to unspecified investors.